http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0188115-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bf5622752f7df8cfda862954eb1dde5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92dd81bdd0d10ed3bc7807859a083297
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-033
filingDate 2001-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ae17c60835c8015d081f9f9e9e526cf
publicationDate 2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0188115-B1
titleOfInvention Transgenic caenorhabditis elegans model exhibiting a neuronal dysfunction
abstract The invention concerns a transgenic nematode exhibiting a transgenic neuron dysfunction phenotype in the apparent absence of neuronal death. The invention also concerns the transgene responsible for said phenotype and methods for screening therapeutic targets and active compounds for treating polyglutamine expansion diseases.
priorityDate 2000-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586568

Total number of triples: 17.